Produkty 80434-32-8

CAS 80434-32-8 występuje w naszej ofercie pod nazwami: 1-beta-Hydroxydeoxycholic Acid, Ursodeoxycholic Acid Impurity 31, Chenodeoxycholic Acid Impurity 13, 1beta-Hydroxydeoxycholic Acid, 1β-Hydroxydeoxycholic acid, 98.00%. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, MedChemExpress. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 10 mg, 1 mg.

1-beta-Hydroxydeoxycholic Acid
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Ursodeoxycholic Acid Impurity 31
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Chenodeoxycholic Acid Impurity 13
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
1beta-Hydroxydeoxycholic Acid
TRC
  • opakowanie: 200mg
  • Warianty: 1
Zobacz produkt
1β-Hydroxydeoxycholic acid, 98.00%
MedChemExpress
  • opakowanie: 10 mg, 1 mg, 5 mg
  • Warianty: 3
od 2089,06
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(4R)-4-[(1R,3S,5R,8S,9S,10S,12S,13R,14S,17R)-1,3,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (CAS 80434-32-8) to związek chemiczny o wzorze sumarycznym C24H40O5 i masie molowej 408.6 g/mol. Nazwa systematyczna IUPAC: (4R)-4-[(1R,3S,5R,8S,9S,10S,12S,13R,14S,17R)-1,3,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid. InChIKey: DAKYVYUAVGJDRK-FPUZENINSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H40O5
Masa molowa408.6 g/mol
Nazwa IUPAC(4R)-4-[(1R,3S,5R,8S,9S,10S,12S,13R,14S,17R)-1,3,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
InChIKeyDAKYVYUAVGJDRK-FPUZENINSA-N
SMILESC[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3([C@@H](C[C@H](C4)O)O)C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 1beta-hydroxydeoxycholic acid, 1beta,3alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid, Cholan-24-oic acid, 1,3,12-trihydroxy-, (1beta,3alpha,5beta,12alpha)-, 1beta,3alpha,12alpha-Trihydroxy-5beta-cholanoic acid, 1 beta, 3alpha, 12alpha-Trihydroxy-5beta-cholanoic acid, 1|A-Hydroxydeoxycholic Acid, 1?-Hydroxydeoxycholic Acid, 1beta-Hydroxydeoxycholic Acid-D4 (major), 1b,3a,12a-trihydroxy-5b-cholan-24-oic acid, 1beta-OH-deoxycholic acid
Powiązane formy tego związku
4-[(1R,3S,5R,8S,9S,10S,12R,13R,17S)-2,2,4,4-tetradeuterio-1,3,12-trihydroxy-10,13-dimethyl-3,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
Izomery (ten sam wzór sumaryczny)
(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E,4R)-4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxocyclopentyl]heptanoate C24H40O5
(4R)-4-[(3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4R)-4-[(3R,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4R)-4-[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-3,5,6-trihydroxy-10,13-dimethyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4R)-4-[(3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4R)-4-[(3R,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4R)-4-[(1R,3S,5S,7S,8S,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4S)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-3-hydroxypentanoic acid C24H40O5
(4R)-4-[(3R,5S,7R,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5
(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C24H40O5